Actemium and Cegelec are responsible for the refurbishment of a vaccine manufacturing facility

Increasing client productivity

In order to boost its production of hepatitis A vaccines, GlaxoSmithKline (GSK) wanted to refurbish its manufacturing facility in Wavre. A consortium comprising Actemium and Cegelec is responsible for the project, providing GSK with a single point of contact and the capability to carry out the works, ranging from construction and production line-related technical aspects right through to HVAC (heating, ventilation, air conditioning).